Zenkuda demonstrated superiority over sham in patients with diabetic retinopathy in the phase 3 GLOW2 study, according to a ...
Two trials showed novel angiography-based physiology assessments were comparable to pressure wire-based approaches for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results